Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

FDA Recall Z-2023-2024 · Posted 2024-06-05

Recall StatusOpen, Classified
Product CodeQJR
Date Initiated2024-05-07
Product Quantity2,061 kits

Reason for Recall

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Firm Action

Consignees were mailed and/or emailed an URGENT: Medical Device Product Correction notification, dated 5/7/24. The notification instructs consignees to immediately inspect their inventory for affected devices and destroy them per the consignee's destruction process, ensure the notification is read and understood, disseminate the notification to among those in your organization and customers who should be made aware, and return the completed Response Form to BD by email to [email protected] or by fax to 312-949-0438. Consignees with any complaints can call 1-844-823-5433 or email [email protected]; consignees with any recall related questions can email [email protected].

Root Cause

Component design/selection

Distribution Pattern

Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑